BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34313965)

  • 21. Paediatric follicular thyroid carcinoma - indolent cancer with low prevalence of RAS mutations and absence of PAX8-PPARG fusion in a Japanese population.
    Vuong HG; Kondo T; Oishi N; Nakazawa T; Mochizuki K; Miyauchi A; Hirokawa M; Katoh R
    Histopathology; 2017 Nov; 71(5):760-768. PubMed ID: 28621837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas: Molecular Characterization and Proposal for a Separate Classification.
    Rooper LM; Bynum JP; Miller KP; Lin MT; Gagan J; Thompson LDR; Bishop JA
    Am J Surg Pathol; 2020 Jun; 44(6):826-833. PubMed ID: 31917706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic DICER1 Mutations in a Pubertal Girl with Cervical Embryonal Rhabdomyosarcoma and Papillary Thyroid Adenoma.
    Zhang L; Ye H; Jin Y; Zhong P; Duan H
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):742-744. PubMed ID: 32682898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
    Jung SH; Kim MS; Jung CK; Park HC; Kim SY; Liu J; Bae JS; Lee SH; Kim TM; Lee SH; Chung YJ
    Oncotarget; 2016 Oct; 7(43):69638-69648. PubMed ID: 27626165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multinodular Goiter Progression Toward Malignancy in a Case of DICER1 Syndrome: Histologic and Molecular Alterations.
    Gullo I; Batista R; Rodrigues-Pereira P; Soares P; Barroca H; do Bom-Sucesso M; Sobrinho-Simões M
    Am J Clin Pathol; 2018 Mar; 149(5):379-386. PubMed ID: 29538609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.
    de Kock L; Sabbaghian N; Soglio DB; Guillerman RP; Park BK; Chami R; Deal CL; Priest JR; Foulkes WD
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1072-7. PubMed ID: 24617712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep Sequencing Reveals Spatially Distributed Distinct Hot Spot Mutations in DICER1-Related Multinodular Goiter.
    de Kock L; Bah I; Revil T; Bérubé P; Wu MK; Sabbaghian N; Priest JR; Ragoussis J; Foulkes WD
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3637-3645. PubMed ID: 27459524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.
    Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL
    Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology.
    Chong AS; Nikiforov YE; Condello V; Wald AI; Nikiforova MN; Foulkes WD; Rivera B
    J Clin Endocrinol Metab; 2021 Mar; 106(4):968-977. PubMed ID: 33460435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
    Yoo SK; Lee S; Kim SJ; Jee HG; Kim BA; Cho H; Song YS; Cho SW; Won JK; Shin JY; Park do J; Kim JI; Lee KE; Park YJ; Seo JS
    PLoS Genet; 2016 Aug; 12(8):e1006239. PubMed ID: 27494611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
    Rutter MM; Jha P; Schultz KA; Sheil A; Harris AK; Bauer AJ; Field AL; Geller J; Hill DA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):1-5. PubMed ID: 26555935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.
    Paulsson JO; Wang N; Gao J; Stenman A; Zedenius J; Mu N; Lui WO; Larsson C; Juhlin CC
    Endocr Relat Cancer; 2020 May; 27(5):295-308. PubMed ID: 32163919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
    Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
    Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metachronous anaplastic sarcoma of the kidney and thyroid follicular carcinoma as manifestations of DICER1 abnormalities.
    Yoshida M; Hamanoue S; Seki M; Tanaka M; Yoshida K; Goto H; Ogawa S; Takita J; Tanaka Y
    Hum Pathol; 2017 Mar; 61():205-209. PubMed ID: 27697588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.
    Nicolson NG; Murtha TD; Dong W; Paulsson JO; Choi J; Barbieri AL; Brown TC; Kunstman JW; Larsson C; Prasad ML; Korah R; Lifton RP; Juhlin CC; Carling T
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2640-2650. PubMed ID: 29726952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
    Wu MK; Vujanic GM; Fahiminiya S; Watanabe N; Thorner PS; O'Sullivan MJ; Fabian MR; Foulkes WD
    Mod Pathol; 2018 Jan; 31(1):169-178. PubMed ID: 28862265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.